In recent years, the cancer profiling market size has grown rapidly, increasing from $13.48 billion in 2024 to an estimated $15.05 billion in 2025, marking a compound annual growth rate (CAGR) of 11.6%. This growth has been primarily driven by increasing cancer incidence rates, a rise in precision medicine approaches, clinical adoption of biomarkers, drug development and targeted therapies, and increasing patient awareness and advocacy.
Furthermore, the cancer profiling market size is predicted to see significant growth in the coming years, potentially reaching $23.08 billion by 2029 at a CAGR of 11.3%. This forecasted growth can be attributed to the integration of artificial intelligence, global collaborations in research, expansion of liquid biopsy applications, regulatory support for precision medicine, and an increasing emphasis on early detection. Major trends forecast for this period include the dominance of liquid biopsy, comprehensive genomic profiling, the rise of immunoprofiling, a collaborative data sharing network, and single-cell sequencing.
Get Your Free Sample of The Global Cancer Profiling Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=9912&type=smp
What Are the Key Growth Drivers of the Cancer Profiling Market?
The increasing incidence of cancer is a significant driver propelling the growth of the cancer profiling market. Cancer incidence refers to the new cancer cases in a specific population over a given period. Increased cancer rates can be attributed to urbanization, a growing aging population, changing lifestyles, and environmental and genetic factors. Cancer profiling assists in identifying specific molecular or genetic changes in a tumor, such as gene mutations or other changes in tumor DNA, proving beneficial in cancer treatment. For instance, in 2022, according to the American Cancer Society, approximately 1.9 million new cancer cases were diagnosed and 609,360 cancer-related deaths occurred in the United States. Therefore, the increasing incidence of cancer significantly contributes to the growth of the cancer profiling market.
What Are The Major Segments In The Global Cancer Profiling Market?
The global cancer profiling market is segmented based on –
1) By Technology: Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization.
2) By Biomarker Type: Genomic Biomarkers, Protein Biomarkers.
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers.
4) By Application: Research Applications, Clinical Applications, Screening, Diagnostics, Prognostics, Other Applications.
Order your report now for swift delivery: https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report
Who Are The Major Players In The Cancer Profiling Market?
Notable companies operating in the cancer profiling market include Illumina Inc., Qiagen NV, NeoGenomics Inc., Sysmex Corporation, HTG Molecular Diagnostics Inc., Caris Life Sciences, NanoString Technologies Inc., Guardant Health Inc., Foundation Medicine Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genscript Biotech Corporation, Tempus Labs Inc., Hologic Inc., and Predictive Oncology Inc., among others.
What Are The Emerging Trends in the Cancer Profiling Market?
Companies in the cancer profiling market are keen on creating innovative solutions. For instance, in March 2022, US-based biotechnology company Illumina, Inc. introduced the TruSight Oncology Comprehensive (TSO) test, marking a significant advancement in cancer diagnostics. This new in vitro diagnostic test profiles cancer mutations, guiding patients towards targeted therapies and analyzes 517 genes across nearly 30 solid tumor types, both DNA and RNA.
Which Region Dominated The Cancer Profiling Market In 2024?
In 2024, North America was the largest region in the cancer profiling market. This market report covers various regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
What Does The Cancer Profiling Market Report 2025 Offer?
Cancer profiling refers to a diagnostic procedure used to analyze the genetic information of tumor cells in the body. This approach provides insights into molecular or genetic changes in a tumor, such as gene mutations or other changes in tumor DNA. The Cancer Profiling Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9912
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
